Target Therapy for Extramedullary Relapse of <i>FLT3</i>-ITD Acute Myeloid Leukemia: Emerging Data from the Field

Target Therapy for Extramedullary Relapse of <i>FLT3</i>-ITD Acute Myeloid Leukemia: Emerging Data from the Field

FMS-like tyrosine kinase 3 (FLT3) is a receptor tyrosine kinase family member. Mutations in <i>FLT3</i>, as well known, represent the most common genomic alteration in acute myeloid leukemia (AML), identified in approximately one-third of newly diagnosed adult patients. In recent years,...

Full description

Bibliographic Details
Main Authors: Andrea Duminuco, Cinzia Maugeri, Marina Parisi, Elisa Mauro, Paolo Fabio Fiumara, Valentina Randazzo, Domenico Salemi, Cecilia Agueli, Giuseppe Alberto Palumbo, Alessandra Santoro, Francesco Di Raimondo, Calogero Vetro
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Cancers
Subjects:
myeloid sarcoma
extramedullary manifestation of AML
<i>FLT3</i>
acute myeloid leukemia
Online Access:https://www.mdpi.com/2072-6694/14/9/2186

Internet

https://www.mdpi.com/2072-6694/14/9/2186

Similar Items